Nederlands
English
Nederlands
Asset Management
Beleggingsstrategieën
Client Solutions
Verantwoord beleggen
Merchant Banking
Corporate Finance
Securities
Over Kempen
Contact
Werken bij
News & Knowledge
kempen
Kempen
Corporate Finance
Cardio3 July 2013
Cardio3
Cardio3 BioSciences floated on Euronext Brussels and Euronext Paris
Proceeds of the IPO were dedicated to fund European phase III trials of its flagship product, C-Cure
Kempen & Co acted as Sole Global Coordinator and Joint Bookrunner